Bryan W. Johnson

1.5k total citations
15 papers, 1.1k citations indexed

About

Bryan W. Johnson is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bryan W. Johnson has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bryan W. Johnson's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (4 papers) and HER2/EGFR in Cancer Research (4 papers). Bryan W. Johnson is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (4 papers) and HER2/EGFR in Cancer Research (4 papers). Bryan W. Johnson collaborates with scholars based in United States and United Kingdom. Bryan W. Johnson's co-authors include Karen Cichowski, Sybil M. Genther Williams, Cory M. Johannessen, Pablo E. Hollstein, Elizabeth E. Reczek, Mia MacCollin, Stéphanie Courtois-Cox, Lawrence Boise, Tyler Jacks and Melanie Jardim and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Bryan W. Johnson

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan W. Johnson United States 8 738 326 193 183 119 15 1.1k
Toshinori Iwahara Japan 7 488 0.7× 377 1.2× 194 1.0× 61 0.3× 106 0.9× 7 1.0k
Carlos Cordon-Cardo United States 7 774 1.0× 479 1.5× 155 0.8× 37 0.2× 86 0.7× 8 1.3k
Sonia Pagliardini Italy 17 610 0.8× 312 1.0× 51 0.3× 60 0.3× 146 1.2× 25 988
Victoria Hill United States 17 729 1.0× 338 1.0× 27 0.1× 102 0.6× 185 1.6× 23 1.2k
Satoko Nakada Japan 13 468 0.6× 178 0.5× 42 0.2× 52 0.3× 84 0.7× 38 970
Miguel A. López-Lago United States 9 563 0.8× 287 0.9× 119 0.6× 34 0.2× 218 1.8× 13 1.1k
Taru Muranen United States 13 555 0.8× 383 1.2× 97 0.5× 25 0.1× 110 0.9× 25 1.1k
Nilgun Tasdemir United States 15 1.1k 1.5× 429 1.3× 35 0.2× 193 1.1× 183 1.5× 26 1.6k
Alessandro Verrecchia Italy 17 1.1k 1.4× 446 1.4× 32 0.2× 106 0.6× 316 2.7× 23 1.4k
Dirk Kemming Germany 15 683 0.9× 423 1.3× 33 0.2× 69 0.4× 134 1.1× 22 1.3k

Countries citing papers authored by Bryan W. Johnson

Since Specialization
Citations

This map shows the geographic impact of Bryan W. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan W. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan W. Johnson more than expected).

Fields of papers citing papers by Bryan W. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan W. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan W. Johnson. The network helps show where Bryan W. Johnson may publish in the future.

Co-authorship network of co-authors of Bryan W. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan W. Johnson. A scholar is included among the top collaborators of Bryan W. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan W. Johnson. Bryan W. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Thomas, Sachdev, Ulka N. Vaishampayan, Bryan W. Johnson, et al.. (2024). Development and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC).. Journal of Clinical Oncology. 42(4_suppl). 467–467.
2.
Johnson, Bryan W. & Judith L. Leatherman. (2021). Merlin and expanded integrate cell signaling that regulates cyst stem cell proliferation in the Drosophila testis niche. Developmental Biology. 477. 133–144. 2 indexed citations
3.
Fitzgerald, Jonathan B., Bryan W. Johnson, Jason Baum, et al.. (2013). MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors. Molecular Cancer Therapeutics. 13(2). 410–425. 87 indexed citations
4.
Xu, Lihui, Neeraj Kohli, Rachel Rennard, et al.. (2013). Rapid optimization and prototyping for therapeutic antibody-like molecules. mAbs. 5(2). 237–254. 21 indexed citations
5.
Euw, Erika M. von, Emily Pace, Diana H. Chai, et al.. (2013). Abstract 2077A: MM141, a novel bispecific antibody co-inhibitor of IGF-1R and ErbB3, inhibits the proliferation of melanoma cells.. Cancer Research. 73(8_Supplement). 2077A–2077A. 2 indexed citations
6.
Maertens, Ophélia, Bryan W. Johnson, Pablo E. Hollstein, et al.. (2012). Elucidating Distinct Roles for NF1 in Melanomagenesis. Cancer Discovery. 3(3). 338–349. 184 indexed citations
7.
Baum, Jason, Bryan W. Johnson, Sharlene Adams, et al.. (2012). Abstract 2719: MM-141, a novel bispecific antibody co-targeting IGF-1R and ErbB3, blocks ligand-induced signaling and demonstrates antitumor activity. Cancer Research. 72(8_Supplement). 2719–2719. 3 indexed citations
8.
Baum, Jason, Bryan W. Johnson, Sharlene Adams, et al.. (2012). 316 MM-141, a Novel Bispecific Antibody Co-targeting IGF-1R and ErbB3, Inhibits PI3K/Akt/mTOR Pro-survival Signaling in Preclinical Cancer Models. European Journal of Cancer. 48. 97–97. 2 indexed citations
9.
Lugovskoy, Alexey A., Bryan W. Johnson, Jason Baum, et al.. (2011). Abstract B205: Therapeutically targeting redundant, growth factor-induced prosurvival signaling with MM-141, a novel bispecific antibody targeting IGF-1R and ErbB3.. Molecular Cancer Therapeutics. 10(11_Supplement). B205–B205. 2 indexed citations
10.
Johannessen, Cory M., Bryan W. Johnson, Sybil M. Genther Williams, et al.. (2008). TORC1 Is Essential for NF1-Associated Malignancies. Current Biology. 18(1). 56–62. 147 indexed citations
11.
Courtois-Cox, Stéphanie, Sybil M. Genther Williams, Elizabeth E. Reczek, et al.. (2006). A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell. 10(6). 459–472. 403 indexed citations
12.
Cichowski, Karen, et al.. (2003). Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. Genes & Development. 17(4). 449–454. 111 indexed citations
13.
Cepero, Enriqué, Bryan W. Johnson, & Lawrence Boise. (2001). Chapter 2 Cloning and analysis of Bcl-2 family genes. Methods in cell biology. 66. 29–47. 4 indexed citations
14.
Johnson, Bryan W., Enriqué Cepero, & Lawrence Boise. (2000). Bcl-xL Inhibits Cytochrome c Release but Not Mitochondrial Depolarization during the Activation of Multiple Death Pathways by Tumor Necrosis Factor-α. Journal of Biological Chemistry. 275(40). 31546–31553. 52 indexed citations
15.
Johnson, Bryan W. & Lawrence Boise. (1999). Bcl-2 and Caspase Inhibition Cooperate to Inhibit Tumor Necrosis Factor-α-induced Cell Death in a Bcl-2 Cleavage-independent Fashion. Journal of Biological Chemistry. 274(26). 18552–18558. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshinori Iwahara Breakdown of academic impact, for papers by Carlos Cordon-Cardo Breakdown of academic impact, for papers by Sonia Pagliardini Breakdown of academic impact, for papers by Victoria Hill Breakdown of academic impact, for papers by Satoko Nakada Breakdown of academic impact, for papers by Miguel A. López-Lago Breakdown of academic impact, for papers by Taru Muranen Breakdown of academic impact, for papers by Nilgun Tasdemir Breakdown of academic impact, for papers by Alessandro Verrecchia Breakdown of academic impact, for papers by Dirk Kemming
Rankless by CCL
2026